<DOC>
	<DOC>NCT02576366</DOC>
	<brief_summary>Single center, open label crossover study with 2 treatment phases in healthy volunteers. The potential of phenotypic drug probes to predict drug-drug interactions between tacrolimus, voriconazole and rifampin will be assessed.</brief_summary>
	<brief_title>Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Male Age over 18 years Written informed consent Female Medical comorbidities Use of concomitant medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>